Furthermore, CREB, a transcription factor that plays a crucial role in synaptic plasticity and neurogenesis, has been implicated in the pathophysiology of depression and is considered a potential target for antidepressant therapies [5, 20, 49, 63, 64]. This evidence concerns the gene CREB1 and depressive symptom measurement.